Search Results - "Poznansky, Mark"

Refine Results
  1. 1
  2. 2

    CXCR4 antagonist AMD3100 (plerixafor): From an impurity to a therapeutic agent by Wang, Jingzhe, Tannous, Bakhos A., Poznansky, Mark C., Chen, Huabiao

    Published in Pharmacological research (01-09-2020)
    “…[Display omitted] AMD3100 (plerixafor), a CXCR4 antagonist, has opened a variety of avenues for potential therapeutic approaches in different refractory…”
    Get full text
    Journal Article
  3. 3

    Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity by Garcia-Beltran, Wilfredo F., Lam, Evan C., St. Denis, Kerri, Nitido, Adam D., Garcia, Zeidy H., Hauser, Blake M., Feldman, Jared, Pavlovic, Maia N., Gregory, David J., Poznansky, Mark C., Sigal, Alex, Schmidt, Aaron G., Iafrate, A. John, Naranbhai, Vivek, Balazs, Alejandro B.

    Published in Cell (29-04-2021)
    “…Vaccination elicits immune responses capable of potently neutralizing SARS-CoV-2. However, ongoing surveillance has revealed the emergence of variants…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    A HABA dye-based colorimetric assay to detect unoccupied biotin binding sites in an avidin-containing fusion protein by Mukherjee, Sonia, Leblanc, Pierre, Poznansky, Mark C, Sluder, Ann E

    Published in BioTechniques (13-09-2024)
    “…Avidin-biotin binding, the most robust non-covalent protein-ligand interaction occurring in nature, has wide-ranging applications in biotechnology. A frequent…”
    Get full text
    Journal Article
  7. 7

    Rethinking the role of hydroxychloroquine in the treatment of COVID‐19 by Meyerowitz, Eric A., Vannier, Augustin G. L., Friesen, Morgan G. N., Schoenfeld, Sara, Gelfand, Jeffrey A., Callahan, Michael V., Kim, Arthur Y., Reeves, Patrick M., Poznansky, Mark C.

    Published in The FASEB journal (01-05-2020)
    “…There are currently no proven or approved treatments for coronavirus disease 2019 (COVID‐19). Early anecdotal reports and limited in vitro data led to the…”
    Get full text
    Journal Article
  8. 8

    Mathematical Modeling to Simulate the Effect of Adding Radiation Therapy to Immunotherapy and Application to Hepatocellular Carcinoma by Sung, Wonmo, Hong, Theodore S., Poznansky, Mark C., Paganetti, Harald, Grassberger, Clemens

    “…To develop a comprehensive framework to simulate the response to immune checkpoint inhibitors (ICIs) in combination with radiation therapy (RT) and to apply…”
    Get full text
    Journal Article
  9. 9

    Immunomodulatory drugs: a promising clinical ally for cancer immunotherapy by Colley, Abigail, Brauns, Timothy, Sluder, Ann E., Poznansky, Mark C., Gemechu, Yohannes

    Published in Trends in molecular medicine (01-08-2024)
    “…Immunomodulatory drugs (IMiDs) are well-established anticancer agents for the treatment of haematological malignancies, in particular multiple myeloma…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Standardized guinea pig model for Q fever vaccine reactogenicity by Baeten, Laurie A, Podell, Brendan K, Sluder, Ann E, Garritsen, Anja, Bowen, Richard A, Poznansky, Mark C

    Published in PloS one (12-10-2018)
    “…Historically, vaccination with Coxiella burnetii whole cell vaccines has induced hypersensitivity reactions in humans and animals that have had prior exposure…”
    Get full text
    Journal Article
  12. 12

    Targeting metabolic pathways to counter cancer immunotherapy resistance by Agarwala, Yuki, Brauns, Timothy A., Sluder, Ann E., Poznansky, Mark C., Gemechu, Yohannes

    Published in Trends in immunology (01-07-2024)
    “…Metabolic modifiers can be efficacious in improving immune cell infiltration for various immunotherapeutic approaches, including immune checkpoint inhibitors,…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Mature B cells accelerate wound healing after acute and chronic diabetic skin lesions by Sîrbulescu, Ruxandra F., Boehm, Chloe K., Soon, Erin, Wilks, Moses Q., Ilieş, Iulian, Yuan, Hushan, Maxner, Ben, Chronos, Nicolas, Kaittanis, Charalambos, Normandin, Marc D., El Fakhri, Georges, Orgill, Dennis P., Sluder, Ann E., Poznansky, Mark C.

    Published in Wound repair and regeneration (01-09-2017)
    “…Chronic wounds affect 12–15% of patients with diabetes and are associated with a drastic decrease in their quality of life. Here, we demonstrate that purified…”
    Get full text
    Journal Article
  17. 17
  18. 18

    B cell treatment promotes a neuroprotective microenvironment after traumatic brain injury through reciprocal immunomodulation with infiltrating peripheral myeloid cells by Dwyer, Liam J, Maheshwari, Saumya, Levy, Emily, Poznansky, Mark C, Whalen, Michael J, Sîrbulescu, Ruxandra F

    Published in Journal of neuroinflammation (31-05-2023)
    “…Traumatic brain injury (TBI) remains a major cause of death and severe disability worldwide. We found previously that treatment with exogenous naïve B cells…”
    Get full text
    Journal Article
  19. 19

    Harnessing CXCL12 signaling to protect and preserve functional β-cell mass and for cell replacement in type 1 diabetes by Alagpulinsa, David A., Cao, Jenny J.L., Sobell, Don, Poznansky, Mark C.

    Published in Pharmacology & therapeutics (Oxford) (01-01-2019)
    “…Type 1 diabetes (T1D) is a complex multifactorial disease characterized by autoimmune destruction of insulin-producing pancreatic β cells. Our understanding of…”
    Get full text
    Journal Article
  20. 20